Ebola Bundibugyo Virus Disease Outbreak in DRC
The CDC has issued a Level 4 - Do Not Travel advisory for Ituri and Nord-Kivu provinces in the Democratic Republic of the Congo due to an ongoing Bundibugyo virus disease (BVD) outbreak as of August 2026.
Geographic Scope
The alert specifically affects:
- Ituri Province
- Nord-Kivu (North-Kivu) Province
All non-essential travel to these provinces is strongly discouraged.
About Bundibugyo Virus Disease
Bundibugyo virus is one of six known species of Ebola virus. Like other filoviruses, it causes severe hemorrhagic fever with high mortality rates. The virus is transmitted through direct contact with blood or body fluids of infected individuals, or with surfaces/materials contaminated by these fluids. Human-to-human transmission occurs through exposure during care of patients or preparation of deceased individuals for burial.
Exceptions to Avoidance
The CDC acknowledges that some travelers may proceed to affected areas solely for:
- Humanitarian aid work
- Emergency response operations
- Essential public health interventions
Individuals undertaking such critical missions should consult with their organizations' occupational health and safety programs and CDC travel medicine specialists before departure.
Key Precautions for At-Risk Groups
Travelers with legitimate reasons to enter affected provinces should:
- Maintain strict infection prevention protocols
- Avoid contact with ill persons and deceased individuals
- Practice rigorous hand hygiene and use appropriate personal protective equipment
- Avoid bushmeat consumption and contact with wildlife
- Remain informed through embassy communications and local health authorities
Pre-Travel Health Consultation
Any traveler considering entry to the DRC should schedule a pre-travel health appointment with a travel medicine clinic or infectious disease specialist, regardless of destination province.
Pharmacist's Note: While no specific post-exposure prophylaxis medications are standard recommendations for the general public, certain experimental therapeutics may be available for healthcare workers and emergency responders through occupational health programs. Pharmacists should direct inquiries to occupational medicine departments. Standard preventive measures—personal protective equipment, hygiene practices, and avoiding high-risk exposures—remain the primary defense. Travelers should verify current vaccination requirements for DRC entry and ensure routine immunizations are up-to-date before any travel consideration.